
NASDAQBasic MaterialsAgricultural Inputs
最新データ
$0.3282
−$0.0063 · -1.88%
Bioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.
前日終値
$0.3282
−$0.0063 · -1.88%
時間外
$0.3282
$0.00 · 0.00%
10月8日 19:30 ET
日中の時刻はETです。市場データは遅延する場合があります。
Bioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.
日中レンジ
現在 $0.3282
52週レンジ
現在 $0.3282
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
売り
バリュエーション
47
適正価値
センチメント
40
弱気
リスク
66
高リスク
モメンタム
19
強い下落
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Bioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.
日中レンジ
現在 $0.3282
52週レンジ
現在 $0.3282
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2026年度 | 2025年度 | 2024年度 | 2023年度 | 2022年度 |
|---|---|---|---|---|---|
| 売上高 | 2.38億 USD | 3.33億 USD | 4.65億 USD | 4.19億 USD | 3.28億 USD |
| 売上原価 | 1.55億 USD | 2.05億 USD | 2.83億 USD | 2.39億 USD | 2.02億 USD |
| 粗利益 | 8240万 USD | 1.28億 USD | 1.82億 USD | 1.8億 USD | 1.26億 USD |
| 研究開発 | — | 1491.48万 USD | 1718.3万 USD | 1534.53万 USD | 694.75万 USD |
| 販売・一般管理 | 8230万 USD | 8834.52万 USD | 9426.66万 USD | 8554.06万 USD | 5735.9万 USD |
| 営業費用 | 8230万 USD | 1.29億 USD | 1.37億 USD | 1.12億 USD | 8490.51万 USD |
| 支払利息 | 5090万 USD | 2562.99万 USD | 2687.2万 USD | 2378.81万 USD | 1792.62万 USD |
| 減価償却費と償却費 | — | 2218.22万 USD | 2129.53万 USD | 1939.06万 USD | 918.79万 USD |
| 営業利益 | 10万 USD | −76.19万 USD | 4482.1万 USD | 5418.4万 USD | 3986.99万 USD |
| 純利益 | −2.3億 USD | −5541.61万 USD | 324.3万 USD | 1877.99万 USD | −719.96万 USD |
会社概要が更新されました 2026年10月9日.
直近の発表実績
直近の発表実績
この株式へのエクスポージャーを報告している上場投資信託です。
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。